[
  {
    "ts": "2025-07-30T11:22:00+00:00",
    "headline": "Aldevron Launches New Innovation Center in Waltham, MA",
    "summary": "FARGO, N.D. & WALTHAM, Mass., July 30, 2025--Aldevron is expanding into Waltham, MA, a strategic move to help grow its innovation capabilities in gene editing and mRNA.",
    "url": "https://finance.yahoo.com/news/aldevron-launches-innovation-center-waltham-112200765.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "236de798-1dcb-3491-b8b0-e93f3cb842a4",
      "content": {
        "id": "236de798-1dcb-3491-b8b0-e93f3cb842a4",
        "contentType": "STORY",
        "title": "Aldevron Launches New Innovation Center in Waltham, MA",
        "description": "",
        "summary": "FARGO, N.D. & WALTHAM, Mass., July 30, 2025--Aldevron is expanding into Waltham, MA, a strategic move to help grow its innovation capabilities in gene editing and mRNA.",
        "pubDate": "2025-07-30T11:22:00Z",
        "displayTime": "2025-07-30T11:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/546ffeb1455f68310bc9a0bf814ebd6c",
          "originalWidth": 2400,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gdUhg8bInMFaQpQJFaNFjQ--~B/aD02MDA7dz0yNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/546ffeb1455f68310bc9a0bf814ebd6c.cf.webp",
              "width": 2400,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WGuRZfxSdBlMs5vvNfQ1hA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/546ffeb1455f68310bc9a0bf814ebd6c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/aldevron-launches-innovation-center-waltham-112200765.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/aldevron-launches-innovation-center-waltham-112200765.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-30T09:08:00+00:00",
    "headline": "Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",
    "summary": "The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced public awareness, and strict laws. Technological advancements in testing and an increased emphasis on preventative healthcare further boost the market. Key product and service segments include analyzers, rapid testing devices, and laboratory services, with urine tests dominating",
    "url": "https://finance.yahoo.com/news/drug-abuse-testing-market-forecast-090800366.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "bbda720e-cf71-3767-82ad-20e5188f3662",
      "content": {
        "id": "bbda720e-cf71-3767-82ad-20e5188f3662",
        "contentType": "STORY",
        "title": "Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",
        "description": "",
        "summary": "The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced public awareness, and strict laws. Technological advancements in testing and an increased emphasis on preventative healthcare further boost the market. Key product and service segments include analyzers, rapid testing devices, and laboratory services, with urine tests dominating",
        "pubDate": "2025-07-30T09:08:00Z",
        "displayTime": "2025-07-30T09:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/4df3b016cda8610911554a6b20bdd3d4",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Drug Abuse Testing Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5_PZe5XMvtg1xZii1hzDsg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/4df3b016cda8610911554a6b20bdd3d4.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pKN9ltmf8ZmEE.p052KpuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/4df3b016cda8610911554a6b20bdd3d4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/drug-abuse-testing-market-forecast-090800366.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/drug-abuse-testing-market-forecast-090800366.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            },
            {
              "symbol": "LH"
            },
            {
              "symbol": "DGX"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "TMO"
            },
            {
              "symbol": "BIO"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-30T08:20:00+00:00",
    "headline": "Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever",
    "summary": "Being a great investor doesn't have to be complicated or expensive.",
    "url": "https://www.fool.com/investing/2025/07/30/got-500-blue-chip-dividend-stocks-buy-and-hold/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f5d3e668-1a4d-3f97-b368-f29a332e6534",
      "content": {
        "id": "f5d3e668-1a4d-3f97-b368-f29a332e6534",
        "contentType": "STORY",
        "title": "Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever",
        "description": "",
        "summary": "Being a great investor doesn't have to be complicated or expensive.",
        "pubDate": "2025-07-30T08:20:00Z",
        "displayTime": "2025-07-30T08:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/a624b250a61c3741ca7f786c4497483e",
          "originalWidth": 1400,
          "originalHeight": 750,
          "caption": "Pills spilled in a dollar sign pattern.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eO9FXWoaLJ3me00HH.NnWg--~B/aD03NTA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/a624b250a61c3741ca7f786c4497483e.cf.webp",
              "width": 1400,
              "height": 750,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1.oN0XSk.hH8of3_1_bLjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/a624b250a61c3741ca7f786c4497483e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/07/30/got-500-blue-chip-dividend-stocks-buy-and-hold/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/got-500-3-blue-chip-082000202.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-30T07:37:51+00:00",
    "headline": "Jim Cramer on Danaher: “I Think We’ve Finally Reached the Tipping Point”",
    "summary": "Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer shed light on. While discussing the stock’s condition over the past couple of years, Cramer showed a positive sentiment toward the stock, as he said: “Now, we bought this one in early 2022… I expected the business to stabilize and the stock to make a […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-danaher-think-ve-073751148.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a36ee0ca-fb50-37fd-bb08-785b2dd872a5",
      "content": {
        "id": "a36ee0ca-fb50-37fd-bb08-785b2dd872a5",
        "contentType": "STORY",
        "title": "Jim Cramer on Danaher: “I Think We’ve Finally Reached the Tipping Point”",
        "description": "",
        "summary": "Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer shed light on. While discussing the stock’s condition over the past couple of years, Cramer showed a positive sentiment toward the stock, as he said: “Now, we bought this one in early 2022… I expected the business to stabilize and the stock to make a […]",
        "pubDate": "2025-07-30T07:37:51Z",
        "displayTime": "2025-07-30T07:37:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/61065709a1bdf54b4284c76a9977e4c9",
          "originalWidth": 6000,
          "originalHeight": 4000,
          "caption": "Jim Cramer on Danaher: \"I Think We’ve Finally Reached the Tipping Point\"",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u0Jx9wK257pNJaUWpQ9qIA--~B/aD00MDAwO3c9NjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/61065709a1bdf54b4284c76a9977e4c9.cf.webp",
              "width": 6000,
              "height": 4000,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzmHHjtHLbB7rGD4UgAsIQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/61065709a1bdf54b4284c76a9977e4c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-danaher-think-ve-073751148.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-danaher-think-ve-073751148.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]